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Differential TCR Signaling Regulates
Apoptosis and Immunopathology
during Antigen Responses In Vivo
(NGF) receptor, OX40, DR3±5, and others. Members of
this gene superfamily play crucial and diverse roles in
immunity, especially in processes involving apoptosis
(Nagata, 1997). However, Fas and TNF receptors are
expressed on most activated T cells and have no intrin-
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National Institutes of Health of activated T cells by FasL or TNF (Hornung et al., 1997;
Wong et al., 1997) and ensure clonotype specificity ofBethesda, Maryland 20892±1892
T cell elimination is not presently known.
Although multiple mechanisms participate in control-
ling mature T cell immune responses, recent investiga-Summary
tions have placed special emphasis on antigen-induced
apoptosis (Lenardo et al., 1995). It is now generallyClonal selection theories postulate that lymphocyte
thought that apoptosis of lymphocytes mediated by thefate is regulated by antigen receptor specificity. How-
Fas pathway contributes to peripheral immune homeo-ever, lymphocyte apoptosis is induced through non-
stasis and tolerance. Compelling support for this infer-antigen-specific receptors such as Fas (CD95/APO-1)
ence comes from the observation that severe lymphade-or TNFR. We define a selective TCR that controls apo-
nopathy and autoimmune disease in mice and humansptosis by Fas or TNFR stimulation. Variant ligands can
results from deleterious mutations in the apt1 (Fas) genedeliver this ªcompetence to dieº signal without the full
(Watanabe-Fukunaga et al., 1992; Fisher et al., 1995;TCR signals necessary for cytokine synthesis. These
Rieux-Laucat et al., 1995). However, the expression ofpartial agonists regulate T cell deletion in vivo even
Fas and its ligand occur as part of an overall antigenwhen Fas or TNF is provided by T cells of unrelated
response involving lymphokine secretion and other mo-specificity, but they do not cause the liver necrosis
lecular events characteristic of lymphocyte activation.that is associated with T cell elimination by the full
This raises the possibility of collateral damage as a sec-agonist. Thus, selective signaling ligands regulate T
ondary event either through Fas ligand or other damagingcell deletion and immune damage in vivo and may be
lymphokines acting upon host tissues in the proximityimportant for peripheral T cell tolerance.
of dying T cells. The strategies that the immune system
employs to limit damage to the host as it achieves pe-
ripheral lymphocyte homeostasis and tolerance throughIntroduction
deletion are not completely understood. We therefore
explored this question in our studies of the antigenicA central tenetof clonalselection theories of lymphocyte
homeostasis and tolerance is that lymphocyte fate is regulation of Fas- and TNF-induced apoptosis of mature
T cells.regulated by the antigen receptor specificity. This con-
cept has been employed to explain self-tolerance in-
duced during B and T lymphocyte development and, Results
more recently, deletional tolerance involving mature T
cells in the peripheral immune system (Schwartz, 1993). TCR-Induced Apoptosis Is Clonotype Specific
How peripheral T cells that are triggered during protec- To verify that T cell death induced by a full agonist
tive immune responses and have cross-reactivity with peptide is clonally restricted, we first analyzed a mixture
self-peptides are deleted or otherwise regulated in a of cells containing a pigeon cytochrome c (PCC)-spe-
clonotype-specific manner is not well understood. Dur- cific Th1 clone, A.E7 (Hecht et al., 1983), and a heteroge-
ing immune responses, the interaction of activated T neous population of MHC-matched concanavalin A
cells that are cycling in IL-2 with cognate antigen pro- blast (CAB) T cells (Boehme and Lenardo, 1993). Both
vokes an indirect mechanism of programmed death cell populations had been activated and were briskly
caused by apoptosis-inducing molecules such as Fas cycling in response to culture in medium containing IL-2,
ligand (FasL) and tumor necrosis factor (TNF) and their making them highly susceptible to T cell receptor (TCR)-
receptors (Fas, TNFR) (Brunner et al., 1995; Dhein et al., induced death (Lenardo, 1991; CombadieÁ re et al., 1998).
1995; Ju et al., 1995; Zheng et al., 1995). The molecular Restimulation of these cultures with the PCC 88±104
structure of these molecules makes them part of a large peptide in the presence of I-Ek-expressing, antigen-
superfamily of ligand and receptor genes including presenting cells (APC) caused the death of A.E7 in a
CD27, CD30, CD40, the low-affinity nerve growth factor dose-dependent fashion (Figure 1Aa). Death of this T
cell clone was preceded by up-regulation of both Fas-
³To whom correspondence should be addressed (e-mail: lenardo ligand (Figure 2A) and TNF (Figure 2B) (Boehme and
@nih.gov). Lenardo, 1993; Brunner et al., 1995; Dhein et al., 1995;§Present address: Department of Microbiology and Immunology,
Ju et al., 1995; Lenardo et al., 1995; Zheng et al., 1995;Stanford University, Stanford, CA 94305.
CombadieÁ re et al., 1998). Nonetheless, the neighboring‖ Present address: Hopital PitieÂ -SalpeÂ trieÁ re, Bat. CERVI, 83 Bd de
L'Hopital, 75013 Paris, France. cycling CAB T cells that expressed an equivalent or
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Figure 1. Antigen-Induced Death Is Clono-
type Specific
(Aa) Cell death assay using three types of
cells: cycling A.E7, CMFDA-labeled P13.9
APC, and d-He-labeled cycling CAB from
B10.A mice (Boehme et al., 1995). Cells were
incubated for 24 hr in medium alone or in
the presence of PCC 88±104 (wt) peptide or
immobilized anti-CD3e MAb (2C11).
(Ab) Cell death assay using two types of cells:
cycling CMFDA-loaded A.E7 and Vb81 T cell
blasts. Cells were incubated with either im-
mobilized anti-CD3e MAb (2C11) or biotinyl-
ated anti-Vb8 and 1 mg/ml of avidin. Cell loss
for each cell type was measured by flow cyto-
metric counting of viable cells.
(B) Expression of CD95/Apo-1/Fas receptor
on A.E7 cells or CAB by flow cytometry: con-
trol hamster Ig (dotted line) andanti-Fas (solid
line). One of three representative experiments
is shown.
(C) Dose±response analyses of cycling A.E7
cells stimulated with different doses of PCC
(88±104) wt peptide or with variant peptides
R99 or A99 at 100 mM. T cell apoptosis was
measured after stimulation for 24 hr and after
addition of 7 amino-actinomycin D (7-AAD).
All error bars shown represent one SD from
the mean.
(D) R99 or A99 stimulation render A.E7 sus-
ceptible to Fas- or TNFR-mediated apopto-
sis. Cycling A.E7 cells were stimulated with
P13.9 APC preincubated with 100 mM of R99
or A99 in the presence of either medium alone
or biotinylated anti-mouse Fas (Jo2, 10 mg/
ml), avidin (1 mg/ml), and/or TNFa (50 U/ml).
After 24 hr incubation at 378C, A.E7 cells were
stained with fluoresceinated anti-CD4 to dif-
ferentiate them from APC and cell death was
assessed after addition of 7-AAD by flow cy-
tometry.
(E) Cycling AND T cells specific for PCC 88±104 were stimulated with CMFDA-loaded P13.9 APC preincubated with 100 mM of wt, G99, S99,
or D99 in the presence of either medium alone or biotinylated anti-mouse Fas (Jo2, 10 mg/ml), avidin (1 mg/ml), and/or TNFa (50 U/ml). T cell
apoptosis was measured after 24 hr.
greater starting level of Fas and TNF receptors (TNFRs) putative competence to diesignal in A.E7 cellsby testing
a large number of variants of the PCC 88±104 peptidewere spared (Figures 1A and 1B; data not shown). Con-
trol experiments showed that the CAB T cells were able that contain single amino acid changes for lysine-99
(K99) (CombadieÁ re et al., 1998). Substitutions at positionto undergo apoptosis upon direct stimulation through
the TCR/CD3 complex (Figure 1A, anti-CD3e) (Boehme 99 do not affect binding to the I-Ek molecule but rather
alter TCR recognition of the peptide±MHC complex (Jor-and Lenardo, 1993). In a reciprocal experiment, we also
found that the death of Vb8.21 blasts stimulated with gensen et al., 1992; Madrenas et al., 1995). Stimulation
of cycling A.E7 T cells with wild-type (wt) PCC 88±104anti-Vb8 Ab does not cause the death of bystander cy-
cling A.E7 cells, although both T cells died in response peptide inducedapoptosis in a dose-dependent manner
(Figures 1A and 1C) as well as the secretion of the TH1to anti-CD3e (Figure 1Ab). We therefore hypothesized
that engagement of the TCR prior to or at the time of Fas cytokines IL-2, IL-3, and IFNg (CombadieÁ re et al., 1998).
We have previously described two variants, C99 andcross-linking generated a ªcompetence to dieº signal,
without which T cells were spared. Y99, that selectively induced the programmed cell death
(PCD) of A.E7 cells without inducing synthesis of TH1
cytokines (CombadieÁ re et al., 1998). By contrast, twoVariant Peptides Can Selectively Deliver
a Competence to Die Signal in the other variants, R99 and A99, did not stimulate lympho-
kine secretion on their own (CombadieÁ re et al., 1998)Absence of Cell Activation
In pioneering studies, investigators have used altered nor induce death of cycling A.E7 cells (Figure 1C). De-
spite this failure of the R99 and A99 peptides to induceligands, which are typically single amino acid variants
of antigenic peptides, to dissect various components apoptosis or activation cytokines per se, both peptides
had the property of dramatically amplifying T cell apo-of TCR signaling (Evavold et al., 1993; Sloan-Lancaster
et al., 1994; Jameson and Bevan, 1995; Madrenas et al., ptosis in response to antibody cross-linking of Fas,
TNFR, or both together (Figure 1D). Control experiments1995; Madrenas and Germain, 1996). We studied the
Selective Peptide Induction of Apoptosis
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To ensure that this result was not due to a nonspecific
toxic effect of the peptide preparations but rather had
the hallmarks of a response to the peptides as antigens,
we performed additional tests. We examined whether
MHC presentation of the R99 and A99 peptides was
required for inducing susceptibility to apoptosis. We
found that incubation of A.E7 cells with R99 in the pres-
ence of DAP.3 (Ek2) cells, which are the parental cells
for P13.9 (Ek1) APC and lack MHC class II molecules,
failed to allow A.E7 cells to die in response to Fas or
TNFR stimulation (Figure 2C). By contrast, incubation
with R99 in the presence of P13.9 did not induce apopto-
sis in the absence of other stimuli but allowed the cells
to die in response to anti-Fas cross-linking or TNFa.
We also evaluated phosphorylation events that might
indicate direct signaling by the variant peptides through
the TCR (data not shown).Consistent with ourpreviously
published phosphotyrosine analyses (CombadieÁ re et al.,
1998), we found that stimulation with the wt peptide
induces prominent tyrosine-phosphorylated species cor-
responding to the three isoforms of phospho-z (p18,
p21, and p23), CD3e, and ZAP-70, whereas the R99 and
A99 peptides only induced the p21 tyrosine-phosphory-
lated form of TCR-z chain without stable phosphoryla-
tion of ppz23, CD3e, and ZAP-70 (data not shown). Thus,
R99 and A99 peptides combine with MHC to deliver a
genuine TCR signal, which is only part of that seen inFigure 2. Variant Ligands R99 and A99 Do Not Induce Death Mole-
response to full agonist stimulation.cules
(A) Cycling A.E7 cells were stimulated with variants or wt peptide
(100 mM) for 12 hr in presence of metalloproteinase inhibitor and
were stained with PE-conjugated anti-FasL and FITC-conjugated Bystander T Cells that Receive a Competence
anti-CD4. Dead cells were gated out and viable CD41 A.E7 cells to Die Signal Can Undergo Apoptosis When
were analyzed for FasL expression. Exposed to Other Activated T Cells
(B) TNFa production in the same experiment was measured by It was necessary to exclude the possibility that the ef-
ELISA. Results are representative of at least three independent ex-
fects of the R99 and A99 peptides only enhanced theperiments.
effect of artificial stimuli such as the Fas cross-linking(C) Variant peptides must be presented on APCs to promote cell
death. Cycling A.E7 cells were stimulated with either CMFDA-loaded antibody or large amounts of soluble TNF. We therefore
DAP.3 (H-2Ek2) (left side) or P13.9 (H-2Ek1) APC (right side) preincu- investigated whether the competence to die signal could
bated with either medium alone (no peptide) or 100 mM of R99 in regulate interactions between T cells of different speci-
the presence of cross-linked anti-mouse Fas Ab (5 mg/ml) and/or
ficity by establishing the three-cell system illustrated in20 U/ml of TNFa. Cells were incubated for 24 hr at 378C. Percent
Figure 3A. Both the wt PCC 88±104 and the R99 variantcell death was measured by flow cytometry after the addition of PI.
act as full agonists for cycling AND T cells and causeAll error bars are shown and represent one SD from the mean.
death through Fas and TNFR (Figure 3B) as well as IL-2
synthesis (data not shown). We mixed cycling AND andshowed that stimulation of Fas and/or TNFR alone does
A.E7 T cells together with I-Ek1 APC to see if FasL andnot kill cycling A.E7 cells (Figure 1D) and R99 or A99 did
TNF expressed by ANDT cells in response to recognitionnot induce Fas-ligand up-regulation or TNFa secretion
of R99 would eliminate A.E7 T cells that simultaneously(Figures 2A and 2B). Thus, A99 and R99 variant peptides
received the R99 competence to die signal (Figure 3A).appear to deliver a selective signal that renders cycling
AND T cells underwent apoptosis in response to bothA.E7 cells competent to die by the Fas and TNFR
wt and R99 peptides, irrespective of the presence ofpathways.
A.E7 T cells (Figure 3B). By contrast, the R99 peptideWe then investigated whether this phenomenon ap-
caused the death of A.E7 cells only in the presence ofplied to other T cells. We prepared T cells from AND TCR
AND T cells, whereas the wt peptide caused A.E7 cell(Va11/Vb3) transgenic mice that recognize PCC 81±104/
death with or without AND-PCC T cells (Figure 3B). ForEk but bear a structurally different TCR from A.E7 cells
both the wt and R99 peptides, the death of A.E7 or AND-and, consequently, have a different fine specificity.
PCC T cells was abrogated by blocking both FasL andThree variants of the PCC 88±104 peptide, S99, G99 and
TNF, indicating that apoptosis in this system was dueD99, were found that did not induce the death of AND
to these molecules expressed naturally by the AND TT cells or stimulated cytokine secretion. However, each
cells (Figure 3D). Thus, T cells that receive a selectiveof these variant peptides greatly amplified AND T cell
competence to die signal can undergo apoptosis whenapoptosis in the presence of antibody cross-linking of
they encounter physiological levels of FasL or TNFaFas and/or TNFR (Figure 1E). Thus, two distinct cell
produced by T cells of a different specificity in the samepopulations with different TCRs selected unique sets of
competence to die peptides. microenvironment.
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are in proximity to other T cells that express death cyto-
kines.To rigorously test these possibilities, itwas neces-
sary to perform antigen challenges in vivo (Figure 4A).
We adoptively transferred cycling A.E7 T cells and chal-
lenged them in vivo with the A99 and R99 peptides in
the presence or absence of activated T cells specific
for an unrelated antigen, the 46±61 peptide of hen egg
lysozyme (HEL), presented by a different MHC class II
molecule, I-Ak (Babbitt et al., 1985). Activated T cells
against HEL were generated in B10.A mice by immuniz-
ing with the HEL 46±61 peptide and boosting on day 14
(Figure 4A). Control mice received only PBS injections
and therefore lacked activated anti-HEL T cells. The
adoptively transferred A.E7 T cells were labeled with a
fluorescent dye and given intravenously on day 15 to
both groups of mice. Six hours later, the HEL-46±61
peptide was administered by intraperitoneal injection
either alone or together with the wt, R99, or A99 PCC
peptides (Figure 4A). On day 16, the mice were sacrificed
and various tissues were analyzed. In mice that received
no PCC peptides, labeled A.E7 cells were detected in
the spleen and liver but not in lymph nodes (Figures 4B,
5B, and 5C; data not shown). Mice injected with wt PCC
88±104 peptide had over 90% fewer labeled A.E7 cells
in their spleens compared to mice that received no
PCC peptide (Figure 4B; compare wt with PBS). A few
TUNEL1 cells remained, but most were eliminated, indi-
cating very rapid apoptotic death similar to that known
to occur during thymocyte deletion (Figure 4B). More-
over, the disappearance of A.E7 cells was independent
of HEL-reactive T cells because it took place in both
the HEL-injected and control (PBS-injected) mice (Fig-
ure 4B). By contrast, injection of either the R99 or A99
peptide caused significant depletion of A.E7 cells only
in the spleens of animals immunized with HEL 46±61
Figure 3. Cells that Receive a Competence to Die Signal Undergo (48% and 65% cell loss with the R99 and A99 peptides,
Apoptosis in the Presence of Third-Party T Cells Expressing FasL respectively) (Figure 4B, compare PBS group and HEL
or TNF In Vitro group). The loss of A.E7 cells induced by R99 and A99
(A) Scheme of the three-cell system. Activated, cycling AND T cells in HEL-immunized mice was due to apoptosis since
recognize wt PCC 88±104 and the R99 variant as agonists, up-
40%±60% of the remaining cells were TUNEL1, therebyregulate FasL and TNFa, and die by apoptosis. Shown are the hypo-
indicating that a sizable fraction of cells had been pro-thetical interactions between the A.E7 and AND T cells tested in
grammed to die. Thus, the R99 and A99 peptides pro-this experiment.
(B) Cycling T cells from AND-TCR transgenic mice and CMFDA- moted A.E7 cell apoptosis in the spleen only when other
loaded cycling A.E7 cells were added to P13.9 APC preincubated stimulated T cells were present in the mice. Considered
with wt or variant peptides at various concentrations. AND T cells together with our in vitro observations, these data sug-
were stained with PE-conjugated anti-H-2Kb prior to flow cytometry. gest that the in vivo induction of A.E7 cell death was
Cell death was measured after the addition of 7-AAD (Sigma Chemi-
due to the combined effects of the A99 and R99 partialcal Co., St Louis, MO) by flow cytometry.
agonists, which deliver a competence to die signal in(C) To block cell death, Fas-Fc (10 mg/ml) and TNFR-Fc (10 mg/ml)
or both were included in the assay described above. Error bars propinquity to highly activated HEL-specific T cells that
represent one SD from the mean. express death-inducing cytokines.
Deletion of A.E7 by Partial Agonists Occurs
Deletion of T Cells that Receive a Competence without Induction of Severe Liver Necrosis
to Die Signal In Vivo Programming the death of A.E7 cells in vivo by the full
In the course of immune responses, different T cell agonist peptide or the partial agonist peptides allowed
clones are juxtaposed in lymphoid tissues, perhaps even us to compare the effects of these different stimuli on
encountering antigen on the same APC. Therefore, T the whole animal. During routine histopathological anal-
cells expressing death molecules in vivo could elicit the ysis of internal organs, we were surprised to observe
death of T cells of a different specificity if the latter the dramatic appearance of focal sclerotic lesions in the
received a competence to die signal through the TCR. livers of mice receiving A.E7 cells and the wt agonist
On the other hand, the presentation of agonist and par- peptide (Figure5A). As noted above, activated A.E7 cells
tial agonist peptides may not be sufficiently coincident homed primarily to thespleen and liver of adoptive recip-
ients. The lesions that we observed consisted of strikingto induce the competence to die signal in T cells that
Selective Peptide Induction of Apoptosis
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Figure 4. Effect of the A99 and R99 Variant
Peptides on A.E7 Cells In Vivo during Immune
Responses to an Unrelated Antigen
(A) Experimental scheme. Time course of in-
jections of cells and antigens. The asterisk
indicates the time at which death-inducing
peptide challenges were given, as indicated
in (B). See Experimental Procedures for de-
tails.
(B) Spleen cell suspensions were analyzed
for the presence of TCR1CMFDA1 T cells.
Events (1.5 million) were acquired by flow cy-
tometry after staining of the T cells with PE-
conjugated anti-TCRb. Percent TCR1CMFDA1
A.E7 cell loss was calculated compared to
control HEL 1 PBS injected mice in each
group. A fraction of spleen cells was further
analyzed for the presence of remaining apo-
ptotic cells by using a TUNEL assay as de-
scribed by the manufacturer (Trevigen, Gai-
thersburg, MD).
areas of liver cell necrosis that were associated with HEL immunization per se never caused T cell infiltration
of that organ (data not shown). Thus, T cell deletion byvenous thrombosis (regions marked by asterisks in Fig-
ures 5A and 5B). By contrast, liver damage did not the cytokine-inducing full agonist wt peptide is accom-
panied by end-organ damage to the liver, whereas theoccur in mice harboring A.E7 cells and injected with the
R99 or A99 variant peptides or PBS, independently of partial agonists A99, R99, Y99, and C99 permitted anti-
gen-specific T cell deletion but did not induce liver im-whether the mice had been immunized against HEL (Fig-
ure 5B; data not shown). A striking aspect of the liver munopathology.
disease was that there was no evidence of hepatocyte
apoptosis such as has been previously described with Discussion
CD95 cross-linking. Rather, the type of thrombosis and
liver damage that we observed is similar to that pre- Our data reveal a novel facet of antigen regulation of
FasL- and TNF-induced apoptosis and provide insightsviously reported to be caused by tissue factor and pro-
coagulant activity induced by Th1 cytokines (Bierhaus into the biological function of partial agonist peptides
in vivo. Antigen-induced FasL- and TNF-mediated apo-et al., 1995; DelPrete et al., 1995; Schmid et al., 1995).
Thus, we considered the idea that liver damage was due ptosis is important for the maintenance of normal lym-
phocyte homeostasis and peripheral tolerance (Zhengto cytokines secreted by A.E7 cells after wt peptide
stimulation. To investigate this interpretation, we also et al., 1996). Clonal selection theory postulates that lym-
phocyte fate is regulated in an antigen-specific manner.challenged animals with the Y99 and C99 variant PCC
peptides, which are partial agonists that induce FasL, For T cell apoptosis, which depends on death cytokines
and receptors that are not clonally restricted, our investi-TNF, and A.E7 death in the absence of Th1 cytokines
such as IL-2 and IFNg (CombadieÁ re et al., 1998). We gation reveals a novel TCR signal that can regulate T
cell elimination by FasL and TNF pathways. Full agonistfound that Y99 and C99 caused the elimination of A.E7
cells in the livers of adoptive recipients (Figure 6A). Fur- stimulation leads to various effector outcomes including
cytokine secretion, up-regulation of death receptors,thermore, only a slight mononuclear infiltrate but no liver
necrosis remained after treatment with these peptides and death of the T cell. By using variant peptide ligands
to dissect the array of signals emanating from the TCR,(Figure 6B). Since Y99 and C99 induce the FasL and
TNF death cytokines but not other Th1 cytokines (Com- we show that one consequence of antigen stimulation
is the delivery of a competence to die signal that isbadieÁ re et al., 1998), we conclude that the necrotic liver
damage and venous thrombosis is most likely due to Th1 separable from other effector functions and may involve
a minimal set of tyrosine phosphorylation events. Cellscytokine release during TCR-induced T cell elimination,
rather than a consequence of apoptotic T cell death stimulated by the selective competence to die peptides
do not up-regulate death molecules. Rather, we foundinduced by death cytokines. Unlike the wt, C99, and
Y99 peptides, the A99 and R99 ligands allowed A.E7 that ªcompetentº T cellsare susceptible todeath ligands
expressed on neighboring cells, both in vitro and in vivo.deletion in the spleens but not in the livers of HEL-
immunized mice (Figure 5C). This is most likely due to We are investigating the molecular basis of this effect
and so far our data suggest that BCL-Xl is not involved inthe absence of HEL-activated T cells in the liver, since
Immunity
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Figure 5. The Wt Agonist Peptide, but not Partial Signaling Peptides, Induces Liver Damage
Paraffin sections of liver after hematoxylin and eosin stain (American HistoLabs, Gaithersburg, MD) from the experiment described in Figure
4. (A) Liver section (1003 original magnification) from the PBS group injected with A.E7 cells plus either PBS (left panel) or wt PCC 88±104
peptide (right panel), together with HEL 46±61. Liver infarction comprising venous thrombosis and hepatocyte necrosis present throughout
the whole liver are seen after wt peptide treatment only and are indicated by an asterisk. (Ba), (Bb), and (Bc) correspond to the PBS group,
and (Bd), (Be), and (Bf) to the HEL group. Enlargement of liver sections (6303 original magnification) from mice injected with HEL 46±61 plus
the indicated PCC peptides: no peptide (Ba and Bd), wt (Bb and Be), and A99 (Bc and Bf). No areas of liver damage were observed after the
injection of variant peptide A99 in either group; large areas of liver damage after treatment with wt peptide are indicated by an asterisk. (C)
Detection of A.E7 cells by flow cytometric analysis of cell suspensions prepared from the liver. Percent CMFDA1 cells (A.E7) are shown for
each plot. (A), (B), and (C) are from the same experiment.
this phenomenon (CombadieÁ re et al., 1998). We presume The A99 and R99 partial agonists only permitted clono-
type-specific apoptosis in the presence of other acti-that the competency signal for death also occurs in
the context of full signaling by agonists and this could vated T cells. T cell deletion induced by the full agonist
was associated with severe immunopathology due to Texplain the exquisite antigen selectivity found in many
models of T cell deletion (Kawabe and Ochi, 1991; Rus- cells that had homed to the liver; however, the A99 and
R99 peptides caused T cell deletion (in the spleen) butsell et al., 1991; Critchfield et al., 1994; Lenardo et al.,
1995; Alexander-Miller et al., 1996; Brocke et al., 1996; did not stimulate full Th1 responses in the liver and thus
avoided end-organ damage. Liver damage in our modelHornung et al., 1997; Wong et al., 1997). Thus, our data
establish that peptide antigen provides two important appears to be related to the phenotype of activated A.E7
cells that home to the liver in healthy mice and is notsignals for death. The first is needed for death ligand
expression and the second is needed to facilitate the seen in all T cell transfer models (Critchfield et al., 1994).
The partial agonists Y99 and C99, which induce T cellapoptosis signaling pathway at the time of Fas or TNFR
engagement. It is the latter signal whose absence pre- apoptosis directly by the selective production of FasL
and TNF without effector cytokines such as IL-2, IL-3,vents Fas- or TNFR-expressing bystander cells from
undergoing death and preserves the specificity of clonal or IFNg (CombadieÁ re et al., 1998), did not cause liver
damage (Figure 6). This, coupled with the fact that liverselection.
Although partial agonism has been of interest in the cell death was necrotic (and associated with venous
thrombosis) rather than apoptotic, suggests that ef-experimental analysis of TCR signaling, the role of partial
agonist ligands in immune responses in vivo has been fector cytokines, rather than FasL or TNF, caused the
liver immunopathology in the present experiments. Inenigmatic. Our data show how partial agonists could
take part in mature T cell apoptosis regulation in vivo. addition, preliminary data has shown that these necrotic
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with partial agonist properties). Self-peptides that selec-
tively deliver a competence to die signal could promote
apoptosis of the responding T cells when the latter are
exposed to FasL or TNF produced in trans by other T
cells. Other self-peptides might directly induce apopto-
sis without activation of cross-reactive T cells, analo-
gous to the response of A.E7 to the C99 and Y99 altered
ligands. By this concept, cross-reactionswith many self-
peptides would not be damaging, because these partial
agonists would not provoke cytokine release and ef-
fector function but could eliminate cross-reactive T
cells. This model is supported by our finding that splenic
A.E7 cells were deleted and persisting A.E7 cells in the
liver caused no damage in mice injected with the A99
and R99 peptides. Further support for our idea is that
many PCC-related peptides with amino acid substitu-
tions in the K99 position induce either the competence
to die signal or apoptosis directly and fail to induce
effector cytokines such as IL-2 or IFNg (B. C. and M.J. L.,
unpublished data). If the propensity of partial agonist
peptides to induce T cell death in our model is found
to be representative of other antigen systems, then the
elaboration of partial signals by the TCR could promote
tolerance by the benign deletion of activated T cells.
However, we speculate that such a mechanism might
also have the untoward complication of allowing the
immune response to fail when confronted with a rapidly
mutating pathogen such as the human immunodefi-
ciency virus.
Experimental Procedures
Cells
A.E7 is a Th1, CD41 T cell clone specific for the 88±104 fragment
of pigeon cytochrome c (PCC) presented by I-Ek (Hecht et al., 1983).
A.E7 cells were stimulated with (5 mM) PCC in the presence ofFigure 6. Variant Peptides that SelectivelyPromote TCell Apoptosis
irradiated splenocytes from B10.A mice (H-2a). After 48 hr, cells werethrough FasL and TNF Do Not Induce Liver Damage In Vivo
isolated by Ficoll gradient centrifugation and were transferred to(A) Cell suspensions of spleen were analyzed for the presence of
fresh medium containing IL-2 (50±100 IU/ml recombinant humanTCR1CMFDA1 T cells. Events (1.5 million) were acquired by flow
IL-2 [Chiron, Emeryville, CA] or 10%±15% T-Stim [Collaborative Bio-cytometry after staining of the T cellswith PE-conjugated anti-TCRb.
medical Products, Bedford, MA]) and incubated for an additionalPercent TCR1CMFDA1 A.E7 cell loss was calculated and compared
48±96 hr to generate cycling A.E7 cells that are predisposed toto control PBS-injected mice in each group. A fraction of spleen
apoptosis following TCR engagement (Lenardo, 1991). Cycling con-cells was further analyzed for the presence of remaining apoptotic
canavalin A blasts (CAB) were prepared as described (Boehme etcells by using a TUNEL assay as described by the manufacturer
al., 1995) from the spleens of B10.A mice. Cycling Vb8 blasts were(Trevigen, Gaithersburg, MD). Similar results were obtained in the
obtained by stimulating B10.A splenocytes with biotinylated-anti-liver (data not shown).
Vb8 Ab (1 mg/ml) and avidin (1 mg/ml) for 48 hr, followed by transfer(B) Liver sections (1003 original magnification) from the PBS group
to fresh medium containing IL-2 (50±100 U/ml). A PCC (88±104)injected with A.E7 cells plus either PBS, wt PCC 88±104, Y99, or
specific T cell line from H-2b AND TCR transgenic mice (TCR againstC99 peptides. Liver infarction comprising venous thrombosis and
PCC 81±104 presented by I-Ek) was generated by sequential stimula-hepatocyte necrosis that were seen only with wt peptide treatments
tion of lymph node cells with irradiated H-2k splenocytes and PCCare indicated by an asterisk and are present throughout the entire
88±104 peptide. P13.9, L cell transfectants expressing I-Ek, ICAM-1,liver.
and B7.1 (CD80) molecules or DAP-3, the parental L cell line, were
used as antigen-presenting cells (APC) (Madrenas et al., 1995; Com-
badieÁ re et al., 1998).lesions cannot be prevented by zVAD, an inhibitor of
apoptosis (Jaeschke et al., 1998). Thus, our experiments Peptides
show that the outcome of partial agonist stimulation in The sequence of PCC (88±104) is KAERADLIAYLKQATAK. Peptides
vivo can be correlated with the T cell responses to vari- Y99, C99, R99, A99, S99, G99, and D99 are PCC (88±104) variants
in which lysine in position 99 is changed to tyrosine (Y99), cysteineous peptides in vitro.
(C99), and arginine (R99) or alanine (A99), serine (S99), glycine (G99),An important implication of our data is that partial
and aspartate (D99), respectively. All peptides were synthesized byTCR signaling could serve to specifically eliminate T
the Peptide Synthesis Facility, NIAID, NIH, Bethesda, MD.cells in vivo that are stimulated during a protective im-
mune response (where the agonist peptide is derived Apoptosis Assay
from the pathogen) but have significant cross-reactivity Cycling A.E7 cells (5 3 104) and CAB were incubated with 5 3 104
P13.9 cells in the presence of the indicated concentrations of PCCwith self (where the self-peptide is a related structure
Immunity
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